I-124 PET Directed Redifferentiation Therapy for Radioiodine Refractory Thyroid Cancer: the I-FIRST Study

    Project Details

    StatusActive
    Effective start/end date1/06/2131/05/26

    Funding

    • Medical Research Future Fund MRFF